Cancer Treatment
New findings in cancer treatment described from the United States
Published in Vaccine Weekly, May 10th, 2006
Study 1: Fully human monoclonal antibodies to hepatocyte growth factor show therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
"e-Met is a well-characterized receptor tyrosine kinase for hepatocyte growth factor (HGF). Compelling evidence from studies in human tumors and both cellular and animal tumor models indicates that signaling through the HGF/c-Met pathway mediates a plethora of normal cellular activities, including proliferation, survival, migration, and invasion, that are at the root of cancer cell dysregulation, tumorigenesis, and tumor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-10)
More Articles from Vaccine Weekly
- Ebola Virus Vaccine
cAdVax-based bivalent Ebola vaccine induces immunity against Sudan and Zaire Ebola species - HIV/AIDS Vaccine
Robust HIV-specific immune responses were induced by DNA vaccine plus vaccinia virus boost - Tuberculosis Vaccine
Mycobacterium bovis BCG expressing SIV Gag protein induces immune responses - Vaccinia Virus Vaccine
Vaccinia virus mutated in envelope proteins A33R and B5R are immunogenic - Virology
Chimeric SIN/VEE viruses clear Venezuelan equine encephalitis virus from brain - Allergy & Immunology
IgG binding plant N-glycans were generated in rabbits but not in mice - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
